Dynamic Technology Lab’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Dynamic Technology Lab’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,060	Closed	-$302K	–	1527
2023 Q1	$302K	Buy	13,060 +1,290	+11%	+$30.8K	0.03%	794
2022 Q4	$308K	Buy	+11,770	New	+$261K	0.03%	768
2020 Q3	–	Sell	-2,548	Closed	-$29K	–	1432
2020 Q2	$29K	Buy	+2,548	New	+$35.1K	﹤0.01%	933
2016 Q4	–	Sell	-5,259	Closed	-$326K	–	1232
2016 Q3	$326K	Buy	+5,259	New	+$372K	0.09%	461

Other funds holding KDNY

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Dynamic Technology Lab's KDNY Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2023, closing a stake of 13,060 shares — an estimated $302K sold.

Dynamic Technology Lab first reported a position in KDNY in Q3 2016 and held it in 4 quarters. The position peaked at $326K in Q3 2016. 185 funds tracked by Wall St. Rank hold KDNY as of Q2 2023.

Dynamic Technology Lab reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Dynamic Technology Lab sold 13,060 Chinook Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $302K.
Dynamic Technology Lab first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2016 and held it in 4 quarters.
Dynamic Technology Lab's Chinook Therapeutics, Inc. Common Stock position peaked at $326K in Q3 2016.
185 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.